Hepatic impairment Administration of tapentadol resulted in bigger exposures and serum ranges to tapentadol in topics with impaired hepatic perform in comparison with subjects with standard hepatic perform. The ratio of tapentadol pharmacokinetic parameters for the moderate and moderate hepatic impairment teams in comparison to the traditional hepatic function group https://heywoodd924ghg0.wikibriefing.com/user